Skip to main content Skip to navigation

Warwick academic partners with GSK for new chair role in computational pathology

Professor Rajpoot, Director of the Tissue Image Analytics (TIA) Centre at the University of Warwick, has been announced as the new GSK Chair of Computational Pathology at the University of Warwick.

Pathology images contain an immense amount of data which have long been used for diagnosis and prognosis in the practice of medicine. The advent of AI computer vision methods has transformed the practice of pathology leading to a new discipline of computational pathology.

The AI models can perform tasks faster and more accurately than a human pathologist is able to, such as counting cell types, classification and beyond, to tasks that a human pathologist may find difficult or almost impossible to perform such as predicting the genetic status of a tumour.

Combining the data in pathology slides with other sources of data (in what is termed multi-modal data fusion) has the potential to create the next generation of diagnostic tools for medicine, enabling the selection of appropriate medicines for a patient and predicting their disease outcomes.

Left to right: Prof Nasir Rajpoot, Dr Kim Branson (Senior Vice President & Global Head of AI & ML, GSK) and Dr Tony Wood (Chief Scientific Officer, GSK)

Professor Nasir Rajpoot is one of the leading experts and has published extensively in the field and led the creation of unique datasets that have spurred innovation in other Universities and research organizations across the globe.

Professor Rajpoot commented: “I’m delighted to be taking up this position as the Chair and am very much looking forward to strengthening the Warwick-GSK relationship in the future. AI carries immense potential to revolutionise and personalise cancer care and drug development, and engagements like this are critical to realising that potential.”

“Computational pathology is one of the key innovations we are pioneering at GSK and we look forward to bringing these methods to the clinic to support the creation of innovative medicines. Supporting Nasir at Warwick is one of the ways we can help getting ahead of disease together,” said Kim Branson SVP and Global Head of Artificial Intelligence and Machine Learning, GSK.

The new role shows a commitment by GSK to deepen an already existing partnership with Warwick, with Professor Rajpoot’s appointment being the latest in a series of investments in this field at the University.

To find out more about Professor Rajpoot’s pioneering work at Warwick please click here.

To find out more about GSK’s research into the power of AI and machine learning in medicine please click here.